Isolation and characterization of sorbitol-fermenting Shiga toxin (Verocytotoxin)-producing Escherichia coli O157:H- strains in the Czech Republic
Language English Country United States Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
9650984
PubMed Central
PMC105006
DOI
10.1128/jcm.36.7.2135-2137.1998
Knihovny.cz E-resources
- MeSH
- Bacterial Toxins biosynthesis MeSH
- DNA, Bacterial analysis MeSH
- DNA Fingerprinting MeSH
- Escherichia coli O157 classification isolation & purification MeSH
- Feces microbiology MeSH
- Phenotype MeSH
- Phylogeny MeSH
- Genotype MeSH
- Hemolytic-Uremic Syndrome microbiology MeSH
- Escherichia coli Infections microbiology MeSH
- Infant MeSH
- Humans MeSH
- Polymerase Chain Reaction methods MeSH
- Shiga Toxin 1 MeSH
- Sorbitol metabolism MeSH
- Random Amplified Polymorphic DNA Technique MeSH
- Check Tag
- Infant MeSH
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Czech Republic MeSH
- Names of Substances
- Bacterial Toxins MeSH
- DNA, Bacterial MeSH
- Shiga Toxin 1 MeSH
- Sorbitol MeSH
Two sorbitol-fermenting (SF) Shiga toxin-producing Escherichia coli (STEC) O157:H- strains were isolated from patients with hemolytic-uremic syndrome in the Czech Republic in 1995. Their phenotypic and genotypic characteristics and genomic DNA fingerprints were identical or closely related to those of SF STEC O157:H- strains isolated in Germany in 1988 to 1997. This indicates that the Czech isolates belong to the SF STEC O157 clone which is widespread in Germany. It is the first finding of the clone outside Germany.
See more in PubMed
Aleksić S, Karch H, Bockemühl J. A biotyping scheme for Shiga-like (Vero) toxin-producing Escherichia coli O157 and a list of serological cross-reactions between O157 and other Gram-negative bacteria. Zentralbl Bakteriol. 1992;276:221–230. PubMed
Beutin L, Montenegro M A, Orskov I, Orskov F, Prada J, Zimmermann S, Stephan R. Close association of verotoxin (Shiga-like toxin) production with enterohemolysin production in strains of Escherichia coli. J Clin Microbiol. 1989;27:2559–2564. PubMed PMC
Bielaszewska M, Janda J, Bláhová K, Feber J, Potuz̆ník V, Souc̆ková A. Verocytotoxin-producing Escherichia coli in children with hemolytic uremic syndrome in the Czech Republic. Clin Nephrol. 1996;46:42–44. PubMed
Bitzan M, Karch H. Indirect hemagglutination assay for diagnosis of Escherichia coli O157 infection in patients with hemolytic-uremic syndrome. J Clin Microbiol. 1992;30:1174–1178. PubMed PMC
Edwards P R, Ewing W H. Identification of Enterobacteriaceae. 3rd ed. Minneapolis, Minn: Burgess Publishing; 1972. pp. 67–101.
Gunzer F, Böhm H, Rüssmann H, Bitzan M, Aleksić S, Karch H. Molecular detection of sorbitol-fermenting Escherichia coli O157 in patients with hemolytic-uremic syndrome. J Clin Microbiol. 1992;30:1807–1810. PubMed PMC
Heuwelink A E, van de Kar N C A J, Meis J F G M, Monnens L A H, Melchers W J G. Characterization of verocytotoxin-producing Escherichia coli O157 isolates from patients with haemolytic uraemic syndrome in Western Europe. Epidemiol Infect. 1995;115:1–14. PubMed PMC
Hii J H, Gyles C, Morooka T, Karmali M A, Clarke R, DeGrandis S, Brunton J L. Development of verotoxin 2- and verotoxin 2 variant (VT2v)-specific oligonucleotide probes on the basis of the nucleotide sequence of the B cistron of VT2v from Escherichia coli E32511 and B2F1. J Clin Microbiol. 1991;29:2704–2709. PubMed PMC
Karch H, Wiss R, Gloning H, Emmrich P, Aleksić S, Bockemühl J. Hämolytisch-urämisches Syndrom bei Kleinkindern durch Verotoxin-produzierende Escherichia coli. Dtsch Med Wochenschr. 1990;115:485–495. PubMed
Karch H, Böhm H, Schmidt H, Gunzer F, Aleksic S, Heesemann J. Clonal structure and pathogenicity of Shiga-like toxin-producing, sorbitol-fermenting Escherichia coli O157:H−. J Clin Microbiol. 1993;31:1200–1205. PubMed PMC
Karch H, Janetzki-Mittmann C, Aleksić S, Datz M. Isolation of enterohemorrhagic Escherichia coli O157 strains from patients with hemolytic-uremic syndrome by using immunomagnetic separation, DNA-based methods, and direct culture. J Clin Microbiol. 1996;34:516–519. PubMed PMC
Karch H, Schmidt H, Swarzkopf A, Böhler O, Aleksić S, Rowe B. Molecular characterization and epidemiology of sorbitol-fermenting Escherichia coli O157:H−. Fortschr Med. 1997;115:48. . (Abstract.)
Karmali M A, Petric M, Lim C, Fleming P C, Arbus G S, Lior H. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis. 1985;151:775–782. PubMed
Khakhria R, Duck D, Lior H. Extended phage-typing scheme for Escherichia coli O157:H7. Epidemiol Infect. 1990;105:511–520. PubMed PMC
Park C H, Vandel N M, Hixon D L. Rapid immunoassay for detection of Escherichia coli O157 directly from stool specimens. J Clin Microbiol. 1996;34:988–990. PubMed PMC
Rüsmann H, Schmidt H, Heesemann J, Caprioli A, Karch H. Variants of Shiga-like toxin II constitute a major toxin component in Escherichia coli O157 strains from patients with haemolytic uraemic syndrome. J Med Microbiol. 1994;40:338–343. PubMed
Schmidt H, Beutin L, Karch H. Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli O157:H7 strain EDL933. Infect Immun. 1995;63:1055–1061. PubMed PMC
Sneath P H, Sokal R R. Numerical taxonomy. The principles and practice of numerical classification. San Francisco, Calif: W. H. Freeman and Co.; 1973.
Strockbine N A, Marques L R M, Newland J W, Smith H W, Holmes R K, O’Brien A D. Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biological activities. Infect Immun. 1986;53:135–140. PubMed PMC